Technical Insights

Sourcing R-(-)-3-(Carbamoylmethyl)-5-Methylhexanoic Acid: Crystal Habit Shifts

Drop-in Replacement Sourcing: Matching R-(-)-3-(Carbamoylmethyl)-5-methylhexanoic Acid Specifications for Seamless Pregabalin Intermediate Integration

Chemical Structure of R-(-)-3-(Carbamoylmethyl)-5-methylhexanoic acid (CAS: 181289-33-8) for Sourcing R-(-)-3-(Carbamoylmethyl)-5-Methylhexanoic Acid: Solvent-Induced Crystal Habit ShiftsWhen sourcing (R)-(-)-3-(carbamoylmethyl)-5-methylhexanoic acid (CAS 181289-33-8) as a key chiral intermediate for pregabalin, R&D managers must ensure that the material functions as a true drop-in replacement. This means identical performance in downstream amidation and resolution steps without process adjustments. At NINGBO INNO PHARMCHEM CO.,LTD., our R-isomer of 3-(carbamoylmethyl)-5-methylhexanoic acid is manufactured to match the critical quality attributes of originator-sourced material, including enantiomeric excess (>99% ee), impurity profile, and crystal morphology. We focus on cost-efficiency and supply chain reliability, offering the product in IBC and 210L drum packaging. For a detailed analysis of global pricing trends, refer to our R-Isomer 3-(Carbamoylmethyl)-5-Methylhexanoic Acid Bulk Price 2026 report.

Solvent-Induced Crystal Habit Control: Anti-Solvent Addition Rate Effects in Ethyl Acetate vs. Isopropanol on Filter Cake Permeability

Crystal habit profoundly impacts filtration and drying efficiency during 3-(carbamoylmethyl)-5-methylhexanoic acid isolation. In our kilo-lab and pilot-scale campaigns, we observed that rapid anti-solvent addition in ethyl acetate systems tends to produce needle-like crystals that blind filters, while controlled dosing yields compact rhombohedral plates with superior permeability. In isopropanol/water mixtures, the habit shifts toward thicker prisms, but the addition rate must be slowed to avoid oiling out. A stepwise anti-solvent protocol is critical: start with 0.5 volumes of anti-solvent over 30 minutes, seed with 1% micronized (3R)-3-(2-amino-2-oxoethyl)-5-methylhexanoic acid, then add the remaining anti-solvent over 2 hours. This approach reduces filtration time by up to 40% compared to one-shot addition.

Seeding Protocols and Agitation Strategies to Maintain Particle Size Distribution During Continuous Crystallization

For continuous crystallization of this pregabalin intermediate, maintaining a consistent particle size distribution (PSD) is essential for downstream handling. We recommend wet milling a portion of the product slurry to generate seed crystals with a D50 of 20–30 µm. Introduce the seed stream at a controlled rate to maintain 5–10% seed mass relative to the crystallizer inventory. Agitation must be carefully managed: retreat-curve impellers at 150–200 rpm prevent shear-induced secondary nucleation while keeping crystals suspended. A troubleshooting list for PSD drift includes:

  • Check seed activity: Aged seeds may lose surface activity; use freshly milled slurry.
  • Verify supersaturation control: Use inline FTIR or conductivity to maintain constant supersaturation.
  • Inspect impeller condition: Worn blades can create dead zones, leading to bimodal distributions.
  • Monitor anti-solvent feed location: Poor mixing at the feed point causes local high supersaturation and fines generation.

These field-tested adjustments ensure a robust manufacturing process for the R-isomer of 3-(carbamoylmethyl)-5-methylhexanoic acid.

Field-Validated Handling of Non-Standard Parameters: Viscosity Shifts and Impurity-Driven Color Variations in Sub-Zero Processing

During winter campaigns, we noted a non-standard parameter: the viscosity of concentrated (R)-(-)-3-(carbamoylmethyl)-5-methylhexanoic acid solutions in ethyl acetate increases sharply below 5°C, from ~2 cP to over 15 cP. This shift can reduce heat transfer efficiency in jacketed vessels and alter mixing patterns. To compensate, we pre-heat the anti-solvent to 10°C and use wider impeller blades. Another edge-case behavior is a slight yellow tint in batches with trace aldehyde impurities from the synthesis route. While this does not affect purity by HPLC, it can cause rejection in color-sensitive applications. Our process engineers mitigate this by adding a charcoal treatment step when the APHA color exceeds 50. Please refer to the batch-specific COA for exact color specifications.

Supply Chain Reliability and Cost-Efficiency: IBC and 210L Drum Logistics Without REACH Claims

Our logistics focus strictly on physical packaging: we supply (R)-(-)-3-(carbamoylmethyl)-5-methylhexanoic acid in 210L HDPE drums or 1000L IBCs, both with nitrogen blanketing to prevent moisture uptake. We do not claim EU REACH compliance or environmental certifications. Instead, we emphasize dual-source raw material strategies and safety stock agreements to ensure uninterrupted supply. For a European perspective on pricing, see our R-Isomer 3-(Carbamoylmethyl)-5-Methylhexanoic Acid Bulk Price 2026 analysis. Our drop-in replacement is validated against originator material in multiple customer audits, confirming identical performance in pregabalin synthesis.

Frequently Asked Questions

How can I adjust anti-solvent dosing to prevent needle-like crystal formation and optimize filtration throughput during scale-up?

To avoid needle-like crystals, implement a controlled anti-solvent addition profile: begin with a slow initial charge (0.5 volumes over 30 minutes) to establish a seed bed, then ramp up the rate linearly over 2 hours. Use focused beam reflectance measurement (FBRM) to monitor chord length distribution and adjust dosing to maintain a mean chord length above 50 µm. If needles still form, switch from ethyl acetate to an isopropanol/water system, which favors equant habits. Post-crystallization, a 1-hour digest at 5°C above the final temperature can heal crystal defects and improve filter cake permeability.

What is 3 carbamoylmethyl 5 Methylhexanoic acid used for?

3-Carbamoylmethyl-5-methylhexanoic acid is a key chiral intermediate in the synthesis of pregabalin, a medication used to treat neuropathic pain, fibromyalgia, and epilepsy. The (R)-isomer is resolved or inverted to yield the active (S)-pregabalin.

Who is the manufacturer of Rcmh in India?

Several Indian manufacturers produce (R)-3-(carbamoylmethyl)-5-methylhexanoic acid, but NINGBO INNO PHARMCHEM CO.,LTD. offers a competitive drop-in replacement with consistent quality and global logistics support.

What is 3 aminomethyl 5 Methylhexanoic acid?

3-Aminomethyl-5-methylhexanoic acid is the decarbamoylated derivative, often an impurity or degradation product in pregabalin synthesis. It is not the target intermediate but may appear in purity profiles.

What is the CAS number of 3 carbamoylmethyl 5 Methylhexanoic acid?

The CAS number for the racemic mixture is 181289-33-8. The (R)-isomer has the same CAS number, as CAS typically does not specify stereochemistry unless a separate number is assigned.

Sourcing and Technical Support

Our team provides comprehensive analytical support, including chiral HPLC, PSD analysis, and thermal stability data, to ensure seamless integration of our (R)-(-)-3-(carbamoylmethyl)-5-methylhexanoic acid into your pregabalin process. For custom synthesis requirements or to validate our drop-in replacement data, consult with our process engineers directly.